Is The Ensign Group, Inc. overvalued or undervalued?

As of 17 October 2025, The Ensign Group, Inc. has moved from a very expensive valuation grade to attractive. Based on the current metrics, the company appears to be undervalued. Key valuation ratios include a P/E ratio of 30, an EV to EBITDA of 19.44, and a PEG ratio of 0.36, which suggests that the stock may offer growth potential relative to its price.
In comparison to peers, The Ensign Group's P/E ratio of 30 is higher than Encompass Health Corp.'s 20.94, but lower than its own previous valuation. The EV to EBITDA ratio of 19.44 is also more favorable than the risky DaVita, Inc.'s 7.56, indicating a stronger operational performance. Although return data is not available for a direct comparison with the S&P 500, the recent grade change and attractive valuation suggest a positive outlook for the stock.